doi:10.4172/2329-8847.1000166 Mukherjee S, Date A, Patravale V, et al
We also proposed to finalize the status indicator and APC assignments for these codes (with their final CPT code numbers) in the CY 2026 OPPS/ASC final rule with comment period
However, because we have determined that the cost of reporting on these measures outweighs the benefits of retaining them in the program, it would place an undue burden on hospitals and ASCs to continue requiring reporting on these measures for an additional year
Not for human use, medical, veterinary, or household applications
Does adding cagrilintide to tirzepatide provide additional benefit
While not all individual peptides are FDA-approved, many are compounded in FDA-regulated pharmacies